Current Pharmaceutical Design

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?

Editorial Board
Information for Authors
Subscribe to this Title
Ingenta Connect is not responsible for the content or availability of external websites

Volume 13, Number 13, 2007

Contents
Supplementary Data

Articles

Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
pp. 1295-1298(4)
Author: Molteni, Agostino

Favourites:
ADD

Treatment of Experimental Myocarditis via Modulation of the Renin-Angiotensin System
pp. 1299-1305(7)
Authors: Daniels, Melvin D.; Hyland, Kenneth V.; Engman, David M.

Favourites:
ADD

Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis
pp. 1307-1316(10)
Authors: Molteni, Agostino; Wolfe, Lisa F.; Ward, William F.; Hsin Ts'ao, C.; Brizio Molteni, Loredana; Veno, Patricia; Fish, Brian L.; Taylor, Joan M.; Quintanilla, Norma; Herndon, Betty; Moulder, John E.

Favourites:
ADD

Treatment of Radiation Nephropathy with ACE Inhibitors and AII Type-1 and Type-2 Receptor Antagonists
pp. 1317-1325(9)
Authors: Moulder, J. E.; Fish, B. L.; Cohen, E. P.

Favourites:
ADD

Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis
pp. 1327-1333(7)
Authors: Baybutt, Richard C.; Herndon, Betty L.; Umbehr, Joshua; Mein, Jonathan; Xue, Yuan; Reppert, Sara; Van Dillen, Christine; Kamal, Robin; Halder, Anirudha; Molteni, Agostino

Favourites:
ADD

Role of Renin Angiotensin System Inhibitors in Cardiovascular and Renal Protection: A Lesson from Clinical Trials
pp. 1335-1345(11)
Authors: Stojiljkovic, Ljuba; Behnia, Rahim

Favourites:
ADD

Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine
pp. 1347-1361(15)
Authors: Lefebvre, H. P.; Brown, S. A.; Chetboul, V.; King, J. N.; Pouchelon, J.-L.; Toutain, P. L.

Favourites:
ADD

Transplantation and Other Uses of Human Umbilical Cord Blood and Stem Cells
pp. 1363-1373(11)
Authors: Goldstein, Gal; Toren, Amos; Nagler, Arnon

Favourites:
ADD

Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations
pp. 1375-1400(26)
Authors: Garattini, Enrico; Gianni, Maurizio; Terao, Mineko

Favourites:
ADD

Current Pharmaceutical Design

Sign-in

Tools

Share Content